New stool test detects colorectal cancer with 90% accuracy

A new non-invasive stool test detects colorectal cancer with nearly 90% accuracy by analyzing gut bacteria. The test identifies microbial signatures at the subspecies level, offering a more accessible alternative to colonoscopy for early detection. Clinical trials are underway to validate its effectiveness. Colorectal cancer is a leading cause of cancer deaths, and early detection significantly improves survival rates. This test could overcome barriers like fear and discomfort associated with colonoscopies.